SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001485003-20-000030
Filing Date
2020-02-26
Accepted
2020-02-26 17:25:21
Documents
1
Period of Report
2020-02-24

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_158275590275256.html 4  
1 FORM 4 wf-form4_158275590275256.xml 4 3856
  Complete submission text file 0001485003-20-000030.txt   5337
Mailing Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142
Business Address 245 FIRST STREET SUITE 1800 CAMBRIDGE MA 02142 617-444-8550
Sesen Bio, Inc. (Issuer) CIK: 0001485003 (see all company filings)

IRS No.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 3344 NORTH TORREY PINES COURT SUITE 200 LA JOLLA CA 92037
Business Address
Keyes Jason A (Reporting) CIK: 0001678152 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36296 | Film No.: 20657272